A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

Published:2022-02-11 Issue:5 Volume:6 Page:1032-1044
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Pennisi Grazia,Pipitone Rosaria Maria,Enea Marco,De Vincentis Antonio,Battaglia Salvatore,Di Marco Vito,Di Martino Vincenzo,Spatola Federica,Tavaglione Federica,Vespasiani‐Gentilucci Umberto,Zito Rossella,Romeo Stefano,Cammà Calogero,Craxì Antonio,Grimaudo Stefania,Petta Salvatore

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1877

Reference40 articles.

1. Global epidemiology of non‐alcoholic fatty liver disease‐meta‐analytic assessment of prevalence. Incidence and outcomes;Hepatology,2016

2. The natural history of nonalcoholic fatty liver disease: a population‐based cohort study;Gastroenterology,2005

3. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes;Hepatology,2006

4. Liver fibrosis, but no other histologic features, is associated with long‐term outcomes of patients with nonalcoholic fatty liver disease;Gastroenterology,2015

5. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study;Hepatology,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?;United European Gastroenterology Journal;2024-04-24

2. The PD-1/PD-L1 Axis in the Biology of MASLD;International Journal of Molecular Sciences;2024-03-25

3. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease;Clinical Gastroenterology and Hepatology;2023-12

4. The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study;Liver International;2023-07-20

5. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies;Annals of the New York Academy of Sciences;2023-07-03